UPDATE: Goldman Sachs Assumes Magenta Therapeutics (MGTA) at Neutral
Tweet Send to a Friend
(Updated - December 6, 2019 5:26 AM EST)
(update comment)Goldman Sachs analyst Paul Choi assumes primary coverage on Magenta ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(update comment)Goldman Sachs analyst Paul Choi assumes primary coverage on Magenta ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
